The latest business, scientific & regulatory news from the pharmaceutical and biotechnology industries. Trends & international news from global correspondents and breakthroughs in research in Coming Down the Pike.
February 5, 2010
By:Stephanie Sutton
Pharmaceutical Technology Europe
A highly functioning New Product Planning (NPP) group is a company's first line of defence against losses caused by products that fail to reach the market, according to research and consulting firm Best Practices LLC.
 |
February 5, 2010
By:Stephanie Sutton
Pharmaceutical Technology Europe
Capsules that can release their contents at a selected temperature have been developed by researchers in France, and could lead to the development of therapeutic agents that are applied to the skin and triggered locally by rubbing.
|
February 4, 2010
By:Angie Drakulich
ePT--the Electronic Newsletter of Pharmaceutical Technology
Less than a week after president Obama proposed a spending freeze on nonsecurity-related federal programs, the US Food and Drug Administration released its fiscal year 2011 budget request, calling for a 23% increase.
|
February 4, 2010
By:Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
Pfizer's first updated pipeline since its acquisition of Wyeth includes fewer projects than before and is targeted to specific diseases.
|
February 4, 2010
By:Patricia Van Arnum
ePT--the Electronic Newsletter of Pharmaceutical Technology
AstraZeneca announced this week that it plans to undertake further restructuring in its research and development operations, resulting in the elimination of 3500 jobs.
|
February 4, 2010
By:Angie Drakulich
ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration issued a draft guidance for industry, Assessment of Abuse Potential of Drugs, in late January.
|
January 28, 2010
By:Stephanie Sutton
ePT--the Electronic Newsletter of Pharmaceutical Technology
Two US senators have introduced the Nanotechnology Safety Act of 2010, which would establish a program within the US Food and Drug Administration to assess the health and safety implications of nanotechnology in everyday products.
|
January 28, 2010
By:Erik Greb
ePT--the Electronic Newsletter of Pharmaceutical Technology
Keiji Fukuda, special adviser on pandemic influenza to the World Health Organization's (WHO) director-general, told a hearing at the Council of Europe that WHO's response to the influenza (H1N1) pandemic was not improperly influenced by the pharmaceutical industry.
|
January 28, 2010
By:Stephanie Sutton
ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Medicines Agency has launched a public consultation on its Road Map to 2015, a strategic vision that lays out the agency's priorities for the next five years.
|
| 
Achieve optimum FTIR performance, sensitivity, reliability and value with Shimadzu spectrometers.
Introducing the ACQUITY UPLC H-Class System, the new UPLC system for HPLC users
Celebrating 35 years of processing solutions! Join us, May 4-6, in Rosemont, IL.
Introducing the ACQUITY UPLC H-Class System, the new UPLC system for HPLC users
See the latest news from Optima Group pharma.
Buy new and used pharmaceutical equipment, used process equipment and laboratory equipment at LabX. Auctions, classifieds, and post FREE wanted ads to locate equipment.
Try a complimentary sample of the new ultra-pure gasket from Gore PharmBIO Products
Major Biotech & Pharmaceutical Equipment Auction from Pfizer, Merck & More
Special offers on new and improved products from Restek.